Hepatocellular Adenoma in a Patient with Ornithine Transcarbamylase Deficiency
Ornithine transcarbamylase (OTC) deficiency is an X-linked recessive disorder that leads to hyperammonemia and liver damage. Hepatocellular adenoma in OTC deficiency patients has not been previously described. Here we report the first such case to be described in the English language scientific lite...
Saved in:
Main Authors: | Lin Cheng, Yajuan Liu, Wenjing Wang, J. L. Merritt, Matthew Yeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Hepatology |
Online Access: | http://dx.doi.org/10.1155/2019/2313791 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe Hyperammonemia in Late-Onset Ornithine Transcarbamylase Deficiency Triggered by Steroid Administration
by: Jordi Gascon-Bayarri, et al.
Published: (2015-01-01) -
Late-Onset Ornithine Carbamoyltransferase Deficiency Accompanying Acute Pancreatitis and Hyperammonemia
by: Marcel Cerqueira Cesar Machado, et al.
Published: (2013-01-01) -
Focal Nodular Hyperplasia and Hepatocellular Adenoma around the World Viewed through the Scope of the Immunopathological Classification
by: Charles Balabaud, et al.
Published: (2013-01-01) -
Developmental and hormonal regulation of Arabidopsis thaliana ornithine-delta-aminotransferase
by: A. A. Egorova, et al.
Published: (2022-04-01) -
Pathological Diagnosis of Hepatocellular Cellular Adenoma according to the Clinical Context
by: Paulette Bioulac-Sage, et al.
Published: (2013-01-01)